Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients. [electronic resource]
- Gastroenterologie clinique et biologique Jan 2002
- 62-6 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0399-8320
Alanine Transaminase--blood DNA, Viral--blood Drug Resistance, Microbial--genetics Female Gene Products, pol--genetics Hepatitis B virus--enzymology Hepatitis C, Chronic--drug therapy Humans Kidney Transplantation Lamivudine--therapeutic use Liver Transplantation Male Mutation Retrospective Studies Treatment Outcome